what biogen halted its alzheimer's drug trial means for biotech investors
Published 5 years ago • 2.9K plays • Length 5:04Download video MP4
Download video MP3
Similar videos
-
2:54
biogen and eisai to reveal results of alzheimer's drug trial
-
2:41
analyst on what biogen's alzheimer's drug means for the company
-
16:02
what’s the controversy behind biogen’s alzheimer’s drug?
-
3:40
here's what the fda's endorsement of the alzheimer's drug leqembi means for biogen
-
3:45
cramer: biogen's alzheimer's treatment would be 'the biggest drug ever'
-
6:10
the science behind aduhelm, a controversial new alzheimer’s drug | wsj
-
5:31
what is 'bioavailability'?
-
16:45
pengangguran tetap digaji $500, work from home selamanya? alzheimer sembuh! | beritabaik #4
-
4:18
biogen's alzheimer's drug trial ripe for downside: analyst
-
2:56
biogen shares spike after fda approves alzheimer's drug
-
1:53
fda approves biogen alzheimer's drug, first new therapy for the disease in nearly two decades
-
4:41
alzheimer's drug will lead to some societal decisions: analyst
-
3:00
biogen shares drop as big clinics say they won't administer controversial alzheimer's drug
-
3:49
biogen ceo on fda approval for its alzheimer's drug
-
3:20
biogen alzheimer's drug shows positive results
-
4:30
roche's alzheimer drug failing was a tailwind for a biogen rally, mizuho's salim syed
-
4:21
biogen soars on promising results from alzheimer's drug trial
-
1:21
biogen shares drop despite positive alzheimer's drug results
-
1:31
alzheimer's drug decision day: fda to decide on biogen and eisai treatments
-
1:34
biogen shares tumble as alzheimer's drug study is halted
-
2:23
biogen to seek fda approval for alzheimer's drug aducanumab
-
1:54
biogen shares fall after it scraps alzheimer's treatment